Audicin, a Finnish NeuroTech startup utilizing brainwave entrainment and music neuroscience for real-time focus, productiveness, stress restoration and sleep, right now introduced €1.6 million ($1.9 million) in funding.
The spherical consists of non-public funding, follow-on participation from Oura ring co-founder Petteri Lahtela and Virpi Tuomivaara, and help from Enterprise Finland’s selective Deep Tech Accelerator. The elevate builds on Audicin’s earlier pre-Seed spherical backed by Oura’s founding group and brings complete funding to roughly €2.5 million ($3 million).
“The nervous system doesn’t swap on solely when one thing goes incorrect. It’s working all day, adapting to cognitive load, selections, and stress alerts. Audicin is designed to run within the background of actual life, serving to regulate that load within the second, not simply after the very fact. This financing lets us scale into the environments the place regulation is hardest to take care of, together with phone-restricted settings, and produce this functionality into the platforms folks already depend on,” stated Laura Avonius, CEO of Audicin.
Based in Finland in 2022 by Laura Avonius and Dr Victoria Williamson, Audicin develops neurotechnology designed to help real-time stress restoration and sleep by brainwave-entrainment audio protocols grounded in auditory neuroscience and music psychology.
Based on the corporate, its composed music tracks are mixed with true, invisible binaural beats embedded inside a 360-degree spatial sound, designed by its in-house neuroscientists, medical docs, audio engineers and music composers to information the mind into states of calm, restoration, or focus.
Audicin will be accessed utilizing any headphones or earbuds. It might pair with wearables, together with Oura, Apple Watch, Garmin, and Whoop. With a purpose to be utilized in safe, phone-free environments, together with deployments in healthcare and defence settings, the corporate is piloting a standalone, offline, Bluetooth-free Sleep Headband with a pre-installed eight-hour restoration programme constructed round a 1Hz delta protocol related to deep sleep.
The corporate additionally options Audicin for Apps, which presents an SDK that allows third-party platforms to embed its restoration protocols immediately into their merchandise.
With the contemporary funding, the corporate plans to commercialise Audicin’s app and Sleep Headband, and the rollout of Audicin for Apps.
“Audicin doesn’t rely on consumer effort or ultimate circumstances. It features extra like infrastructure: one thing that may function throughout work, relaxation, and in restricted environments. That’s essentially totally different from instruments that require carving out time for wellness, and it’s why we see robust potential each in enterprise deployments and thru Audicin for Apps as platforms start integrating real-time nervous system help immediately into their merchandise,” stated Petteri Lahtela, co-founder of the Oura ring.
The corporate experiences robust industrial progress, with a €6.9 million ($8 million) gross sales pipeline spanning defence, athletic efficiency, and wellness clinic sectors. Since launching Audicin 2.0 in late 2025, the corporate has grown with out paid acquisition, with a 40% enhance in customers over 12 weeks and greater than doubling iOS income previously 90 days.
It states that customers are returning usually, averaging 5.5 classes weekly, with a 69% renewal price and excessive retention after the primary week. Progress has primarily resulted from earned discovery and rising demand for Audicin’s offline gadget.
Audicin’s industrial and go-to-market operations are primarily based in Austin, Texas. Its analysis and product improvement are led by Dr Williamson, a music psychologist and neuroscientist whose work focuses on how sound influences the mind and nervous system.
The corporate is supported by a Medical Advisory Board spanning utilized physiology, scientific follow, and wearable analytics, together with Dr Hannu Kinnunen, former Chief Scientific Officer at Oura; Joel Naukkarinen, MD, an eight-time world champion; and Dr Jenni Hyysalo.
